| The Board of Directors of Milestone Medical Inc. (the “Company”, the “Issuer”) today announced that it has commenced the first shipments of its CompuFlo™ Epidural Instrument to distributors and key opinion leaders in Europe. Since receiving CE Mark marketing clearance for the Company’s epidural instrument, the Issuer has been in negotiations with distributors in a number of countries in Europe and, as previously announced, signed an exclusive agreement with TRIMED Sp.z.o.o. (“Trimed”), one of the largest distributors of diagnostic equipment in Poland. Trimed has purchased a small number of instruments, initially for internal use and training purposes as it ramps up for a formal launch later this year. The CompuFlo™ Epidural Instrument will be launched through a combination of channels, including medical conventions, direct selling to anesthesia departments at public hospitals and private clinics, and a comprehensive marketing initiative to highlight the global and local clinical work underway. Earlier this month the Issuer signed a distribution agreement with Moss S.p.A. (“Moss”), one of the leading distributors of diagnostic and specialty surgery equipment in Italy, with shipments expected to commence in the next few weeks. Over one million epidurals are administered in Italy each year which makes Italy another viable market for the Company’s instruments. Moss’ demonstrated ability to successfully bring innovate medical products to market will help accelerate the Company’s entrée into the Italian marketplace. While CE Mark marketing clearance enables distributors to sell product in Europe, many health systems require further clinical trials before fully adopting a product. The Issuer’s strategy is to start by introducing the epidural instrument to key opinion leaders in target markets that will demonstrate and help publicize the efficacy of the instrument. At the same time, the Company is advancing its North American clinical trials which will provide further validation. In the meantime, the Issuer is actively lining up additional distributors in other European countries and look forward to announcing these in the coming months. Legal basis: Section 3.1 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market”. |
| Data | Imię i Nazwisko | Stanowisko | Podpis | ||
| 2015-06-30 13:56:58 | Joseph D'Agostino | CFO |
